Two simple analytical methods were developed and validated for the analysis of a binary mixture of metoclopramide (MET) and aspirin (ASP). The first method depends on measuring the first derivative amplitudes at 257 nm for MET and at 310 nm for ASP, respectively. The calibration graphs were linear in the range of 0.25-20.0 mg/mL for MET and 10.0 -200.0 mg/mL for ASP. For the second method, good chromatographic separation was achieved using Promosil C 18 column (250 3 4.6 mm i.d., 5 mm particle size). Mobile phase consisting of methanol and 0.02 M phosphate buffer in the ratio of 60:40 (v/v) at pH 4.0 was pumped at a flow rate of 1 mL/min with UV detection at 260 nm. Indapamide was used as an internal standard. The method showed good linearity over the concentration ranges of 0.20-10.0 and 10.0 -200.0 mg/mL with limits of detection of 0.06, 1.81 mg/mL and limits of quantification of 0.17, 5.46 mg/mL for MET and ASP, respectively. The results of the proposed methods were statistically compared with those obtained by the official United States Pharmacopeia method revealing non-significant differences in the performance of the methods regarding accuracy and precision. The suggested methods were successfully applied for the simultaneous analysis of the studied drugs in their co-formulated tablets as well as in their single dosage forms.
Introduction
Metoclopramide (MET; Figure 1A ), 4-amino-5-chloro-N-(2-diethylaminoethyl)-2-methoxybenzamide, is a potent dopamine receptor antagonist (D2-antagonist) used for its antiemetic properties. It is used in disorders of decreased gastrointestinal motility such as gastroparesis or ileuses; in gastro-esophageal reflux disease and dyspepsia; and in nausea and vomiting associated with various gastrointestinal disorders, with migraine, after surgery, and with cancer therapy (1) . Both the United States Pharmacopeia (USP) (2) and the British Pharmacopeia (BP) (3) recommended potentiometric titration methods for determination of MET in raw material using perchloric acid as a titrant. The USP recommended HPLC method for its determination in different dosage forms, while the BP recommended HPLC method for the determination of MET in tablets and injection, and a spectrophotometric method for its determination in oral solution. Several methods were reported for the determination of MET either per se or in pharmaceutical preparations and biological fluids. These methods include spectrophotometry (4 -6) , spectrofluorimetry (7) , HPLC (8 -10) and GC (11) .
Aspirin (ASP; Figure 1B ), 2-acetyloxy-benzoic acid, is an analgesic with antipyretic effect used for the relief of mild-tomoderate pain, fever, minor febrile conditions and for acute and chronic inflammatory disorders (1). The BP described acid-base residual titrimetric method for the analysis of ASP raw material and its tablets (3), while USP recommended residual titration method for raw material and HPLC for its tablets (2) . Several analytical methods have been reported for the determination of ASP in tablets or in human plasma like, spectrophotometry (12, 13) , spectrofluorometry (14, 15) , electrochemical methods (16, 17) , flow injection analysis (18) , GC (19) and HPLC methods (20, 21) .
Combination of MET and ASP is used for relief of the pain associated with migraine (1) . To the best of our knowledge, no analytical methods have been reported for the simultaneous determination of both compounds. The pharmaceutical preparations contain both drugs are reported in Martindale: The Complete Drug Reference (under multi-ingredient preparations section) (1) , and the ratio of the two drugs is very challenging (10 mg MET and 650 mg ASP). Determination of MET in the presence of this high concentration of ASP is very difficult, and this was the motivation of our study.
Experimental

Apparatus
Spectrophotometric analysis was carried out on a Shimadzu (Kyoto, Japan) UV-1601 PC, UV -visible double-beam spectrophotometer with matched 1 cm pathlength quartz cells. The first derivative spectra of both drugs were derived in the wavelength range of 250 -320 nm using Dl ¼ 8 nm for the first derivative of spectra and scaling factor ¼ 10.
HPLC experiments were performed with a Shimadzu LC-20AD Prominence liquid chromatograph (Japan) equipped with a Rheodyne injector valve with a 20-mL loop and a SPD-20A UV detector. Mobile phases were filtered using Millipore filter Sibata and degassed using a Prominence DGU-20A5 degasser.
A Consort NV P-901 pH -Meter (Belgium) was used for pH measurements.
Materials and reagents
All the chemicals used were of Analytical Reagent grade, and the solvents were of HPLC grade.
MET hydrochloride pure sample, batch # 0008M2RW, was generously supplied by Eva Pharma Co., Cairo, Egypt. The purity percentage was 99.95% as found by applying the official titrimetric USP method (2) . ASP, with a purity of 99.90% as determined by the official titrimetric USP method (2), was kindly provided by EL Nasr Pharmaceutical Chemical Company Cairo, Egypt.
Indapamide (IND; Sigma-Aldrich, St. Louis, MO, USA) was used as internal standard in the developed HPLC method.
Primperan w ampoule, batch # 2EG053, labeled to contain 10 mg MET/2 mL, product of Sanofi-Aventis Cairo, Egypt, was purchased from local pharmacy.
Rivo w tablet, batch # 250127, labeled to contain 320 mg ASP/ tablet, product of the Arab Drug Company, Egypt, was purchased from local pharmacy.
Laboratory prepared tablets (650 mg ASP, 10 mg MET hydrochloride, 20 mg talc powder, 15 mg maize starch, 15 mg lactose and 7 mg magnesium stearate per tablet) were investigated.
Methanol, acetonitrile and n-propanol (HPLC grade) were purchased from Sigma-Aldrich (Germany).
Orthophosphoric acid (85%, w/v) was obtained from RiedeldeHa¨en (Sleeze, Germany).
Sodium hydroxide and sodium dihydrogen phosphate were obtained from ADWIC Co. (Cairo, Egypt).
Chromatographic conditions
The analytical column was Promosil C 18 column (250 Â 4.6 mm, 5 mm particle size), Agela Technologies, Telegraph Rd. Wilmington, DE 19808, USA. Mobile phase consisted of methanol and 0.02 M sodium dihydrogen phosphate buffer in the ratio (60:40, v/v), respectively was used. The pH of the mobile phase was adjusted to 4.0, using 0.02 M phosphoric acid and 0.02 M sodium hydroxide, and the flow rate was 1 mL/min. The column was operated at ambient temperature, and the detector wavelength was 260 nm. IND was used as an internal standard.
Standard solutions
Stock solutions containing 200 mg/mL of MET and 200 mg/mL of ASP were prepared in methanol for both methods. IND stock solution containing 200 mg/mL was prepared in methanol. Working solutions were prepared by appropriate dilution of the stock solutions with either methanol (in the spectrophotometric method) or mobile phase (in the HPLC method). The solution of ASP was stable for at least three days without alteration when kept in the refrigerator as indicated by the constancy of the peak area. After the period of three days, a change in the peak area of ASP accompanied by peak splitting. Regarding MET, the solution is stable for seven days without alteration.
General recommended procedures
Construction of calibration graphs
Spectrophotometric method. Working standard solutions of MET and ASP were prepared from the previous stock solutions by serial dilutions with methanol to obtain final concentrations of 0.25-20.0 mg/mL for MET and 10.0-200.0 mg/mL for ASP. The zero order absorption spectra were recorded against methanol. Then, the first derivative of the spectra was derived, and its amplitudes were measured at 257 nm for MET and at 310 nm for ASP. The derivative amplitudes were then plotted against the final concentrations to get the calibration graphs. Alternatively, the corresponding regression equations were derived.
HPLC method. Accurately measured aliquots of the stock solutions were transferred into a series of 10 mL volumetric flasks so that the final concentrations were in the range of 0.2-10.0 mg/ mL for MET and 10.0-200 mg/mL for ASP. To each flask, 1 mL of IND stock solution was added as an internal standard so that its final concentration was 20 mg/mL. Then, the solutions were completed to the volume with the mobile phase and mixed well. Aliquots of 20 mL were injected (triplicate) and eluted with the mobile phase under the optimum chromatographic conditions. The average peak area ratio (drug/IS) against the final concentration of the drug in mg/mL was plotted. Alternatively, the corresponding regression equations were derived.
Analysis of MET/ASP synthetic mixtures
Aliquots of MET and ASP standard solutions keeping the pharmaceutical ratio of 1:65 were transferred into a series of 10 mL volumetric flasks. The procedures described under "Construction of calibration graphs" were then applied. The percentage recoveries were calculated by referring to the calibration graphs, or using the corresponding regression equations.
Analysis of the studied drugs in their co-formulated tablets An accurately weighed amount of the mixed contents of 5 tablets equivalent to (10 mg MET and 650 mg ASP) was transferred into a 100-mL volumetric flask, and about 80 mL of methanol were added. The contents of the flask were sonicated for 30 min, and then completed to the mark with the same solvent. The solution was filtered into 100 mL volumetric flask. Further dilution with the same solvent was performed to get working standard solution to be assayed by subjecting to the general procedures as described under "construction of calibration graphs". The nominal content was calculated either from previously plotted calibration graphs or using the corresponding regression equations.
Analysis of MET in ampoules
The contents of five Primperan w ampoules were mixed well. An accurately measured volume of the solutions equivalent to 10.0 mg MET (based on the labeled amount of the ampoules) was transferred into a clean dry 100 mL volumetric flask and about 80 mL of methanol were added. The contents of the flask were sonicated for 30 min, completed to the mark with the same solvent. The solution was filtered into 100 mL volumetric flask. Further dilution with the same solvent was performed to get working solutions within the concentration range of the developed method. Then, the general procedures described under "construction of calibration graphs" were followed. The nominal content of ampoules was calculated using the corresponding regression equation.
Analysis of ASP in tablets
Ten Rivo w tablets were accurately weighed, finely pulverized and thoroughly mixed. An accurately weighed quantity of the powder corresponding to 20.0 mg ASP (based on the labeled amount of the tablets) was transferred into a 100-mL volumetric flask and about 80 mL of methanol were added. The contents of the flask were sonicated for 30.0 min, completed to the mark with the same solvent. The solution was filtered into 100 mL volumetric flask. Further dilution with the same solvent was performed to get working standard solution to be assayed by subjecting to the general procedure as described under "construction of calibration graphs". The nominal content of tablets was calculated either from a previously plotted calibration graph or using the corresponding regression equation.
Results
First derivative spectrophotometry
The analysis of the studied mixture by conventional spectrophotometric methods is challenging due to the strong overlap of the zero order absorption spectra of both drugs (Figure 2 ), as well as the high difference in their concentrations in tablets. Therefore, we resorted to derivative spectrophotometry in an attempt to analyze the mixture of the two drugs in their tablets. Figures 3 and 4 show the first derivative spectra of both drugs, on the basis of which MET could be determined by measuring its first derivative amplitude at the zero crossing of ASP at 257 nm 
HPLC method
Optimization of the chromatographic performance and system suitability Figure 5 shows typical chromatogram for synthetic mixture of MET and ASP under the described chromatographic conditions, where well-defined symmetrical peaks were obtained after thorough experimental trials that can be summarized as follows:
Choice of column. Three different columns were used for performance investigations, including: Promosil ODS 100 A column (250 Â 4.6 mm i.d., 5 mm particle size), Agela Technologies, Shimadzu VP-ODS column (150 Â 4.6 mm i.d., 5 mm particle size), Shimadzu, Kyoto, Japan, and CLC Shim-Pack C 8 column (250 Â 4.6 mm, 5 mm particle size), Shimadzu, Kyoto, Japan. Experimental studies revealed that the first column was the appropriate one, giving symmetrical, well-defined peaks with good resolution and reasonable time.
Choice of appropriate wavelength. The UV absorption spectra of the methanolic solutions of the studied drugs exhibit maxima at 220, 275 and 320 nm for MET and 235, 280 and 310 nm for ASP (Figure 2) . In our study, we made a scan for the HPLC chromatograms of each drug and their synthetic mixture from 200 to 300 nm to choose the best wavelength for our study. The wavelength of 260 nm was chosen as the optimum one because ASP shows a relatively low absorbance, permitting the determination of both drugs in the recommended ratio.
Mobile phase composition. Several modifications in the mobile phase composition were performed in order to study the possibilities of changing the selectivity, efficiency and resolution of the chromatographic system. These modifications include the pH of the mobile phase, the type and ratio of the organic modifier, the strength of phosphate buffer and the flow rate. The results achieved are summarized in Table I. pH of the mobile phase The effect of changing the pH of the mobile phase on the separation of the test solutes was investigated using mobile phases of pH values ranging from 3 to 7. The change in the pH value of the mobile phase did not significantly affect the retention time of ASP indicating minor change in its polarity. While increasing the pH value of the mobile phase caused broadening of the peak of MET and increased its retention time due to decrease in its polarity. Therefore, pH 4.0 was selected as the optimum pH value yielding well separated symmetrical peaks of the two drugs with the highest number of theoretical plates and the best sensitivity.
Ionic strength of phosphate buffer
The effect of changing the ionic strength of phosphate buffer on the chromatographic performance was investigated using mobile phases containing concentrations ranged from 0.02 -0.05 M. The results shown in Table I revealed that 0.02 M phosphate buffer was the most appropriate giving well-resolved peaks and the highest number of theoretical plates. Trials were made by replacement of phosphate buffer with water, but broad peaks for both drugs with long retention times were obtained.
Ratio of organic modifier
The effect of changing the ratio of organic modifier on the selectivity and retention times of the two drugs was investigated using mobile phases containing 30 -70% (v/v) of methanol. As the ratio of methanol in the mobile phase decreases, the retention of ASP increases, in addition to broadening of its peak. A mobile phase containing methanol: 0.02 M phosphate buffer in the ratio of 60:40 (v/v) was chosen as the best mobile phase since it allowed the separation of MET and ASP within a short analytical run time with reasonable resolution and excellent sensitivity (Table I) .
Type of organic modifier Different organic solvents including acetonitrile, methanol and n-propanol were tried as modifier. Methanol was the organic modifier of choice for optimum chromatographic separation.
Flow rate. The effect of flow rate on the separation of peaks of the studied compounds was studied and a flow rate of 1.0 mL/ min was optimal for good separation in a reasonable time. Flow rate of 1.2 mL/min caused overlapping of the peak of MET with that of solvent front. At the same time, flow rate of 0.8 mL/min resulted in long retention times.
The nature of internal standard. The use of I.S. is very important for providing a well-developed accurate and precise analytical method. There are many advantages for using an internal standard in HPLC methods including correction of injection volume variation and elimination of the error caused by adsorption on the stationary phase or by interference of the sample matrix.
The use of different drugs as internal standards such as ketoconazole, fluctafenine, spironolactone and IND was studied. The most suitable IS was IND because it is more similar in polarity to ASP and MET than the other tested drugs permitting its elution in a reasonable time relative to the studied drugs. So, it was the internal standard of choice and a concentration of 20 mg/mL was used giving well-defined peak.
Validation of the method
The validity of the proposed methods was evaluated regarding linearity, LOD, LOQ, accuracy, precision, robustness, specificity, sample solution stability, mobile phase stability and system suitability. Linearity Under the above described experimental conditions, a linear relationship was established by plotting either the derivative amplitude or the peak area ratio [drug/IS] against the drug concentration in mg/mL for the spectrophotometric or the HPLC method, respectively. The graphs were found to be rectilinear over the concentration ranges cited in Table II . Linear regression analysis of the data gave the following equations:
First derivative spectrophotometry: where P is the peak area ratio, C is the concentration of the drug in mg/mL and r is the correlation coefficient. Statistical analysis (22) of the data gave high value of the correlation coefficient (r) of the regression equation, small values of the standard deviation of residuals (S y/x ), of intercept (S a ) and of slope (S b ), and small value of the percentage relative standard deviation and the percentage relative error (Table II) . These data proved the linearity of the calibration graphs.
Limit of quantitation and limit of detection
The limit of quantitation (LOQ) was determined by establishing the lowest concentration that can be measured below which the calibration graph is non-linear. The limit of detection (LOD) was determined by establishing the minimum level at which the analyte can be reliably detected. LOQ and LOD could be determined according to the ICH guidelines using the following equations (23) .
where S a , standard deviation of the intercept of the calibration curve and b, slope of the calibration curve. LOQ and LOD values for MET and ASP by the proposed methods were calculated by these equations and presented in Table II . Accuracy To test the accuracy of the proposed methods, they were applied to the determination of pure samples of MET and ASP over the studied concentration ranges. As a reference comparison method, the official liquid chromatographic method described at the monograph of ASP tablets in the USP (2) was used for the analysis of both drugs in pure form. Statistical evaluation of the results using the Student's t-test and the variance ratio F-test revealed non-significant difference between the performance of the methods regarding the accuracy and precision, respectively (Table III) . The official USP method (2) described HPLC method using C 18 column and a mobile phase containing sodium 1-heptanesulphonate (2 gm) in a mixture of water:acetonitrile 850:150 (v/v), with UV detection at 280 nm.
Precision
Intraday precision. It was performed for both methods through replicate analysis of three concentrations of the studied drugs in pure form on three successive times within the same day. These concentrations were 2, 4 and 6 mg/mL for MET, and 10, 30 and 50 mg/mL for ASP. The results are abridged in Table IV .
Interday precision. Interday precision was carried out through replicate analysis of three concentrations of the studied drugs on three successive days. The results are summarized in Table IV . The relative standard deviations were found to be very small indicating reasonable repeatability and intermediate precision of the proposed methods.
Robustness of the HPLC method
The robustness of an analytical procedure is a measure of its capacity to remain unaffected by small, but deliberate variations in method parameters. To test the robustness of the proposed HPLC method, one chromatographic variable was varied while keeping all others constant. The studied variables include pH of the mobile phase (4.5 + 0.5) and concentration of phosphate buffer (0.02 + 0.005 M). These minor changes did not affect the separation and resolution of MET and ASP indicating the reliability of the proposed method during normal usage. It was observed that the most critical factor for the separation process is the ratio of methanol and 0.02 M phosphate buffer in the mobile phase, where small variations in such ratio of 60:40 (v/v) caused significant changes in the resolution, peak shape and separation of the test solutes. This should be taken in consideration during preparation of the mobile phase.
Specificity
The specificity of the methods was investigated by observing any interference encountered from common excipients in different formulations. It was shown that these compounds did not interfere with the results of the proposed methods.
Solution stability and mobile phase stability The stability of the stock solutions was determined by quantitation of MET and ASP and comparison with freshly prepared standard solutions. No significant change was observed in standard solutions response, relative to freshly prepared standard solutions. Similarly, the stability of the mobile phase was checked. The results obtained in both cases proved that the sample solution and mobile phase used during the assay were stable up to 7 and 3 days, respectively.
System suitability System suitability test (SST) parameters were performed during the development and optimization of the method to ensure that the system is working correctly during the analysis. The test was performed by injecting the standard mixture in triplicate, and the parameters were calculated as reported by the USP (2) and the ICH guidelines (23) . The final SST parameters including tailing factor (T), column efficiency (number of theoretical plates, N), selectivity factor (a) and resolution factor (R s ) were summarized in Table I . 
Pharmaceutical application
Analysis of laboratory prepared mixtures
The proposed methods were successfully applied to the determination of the studied drugs in their laboratory prepared mixtures (Table V) . The average percent recoveries were based on the average of three replicate determinations.
Dosage form analysis
The proposed methods were successfully applied to the determination of the studied drugs in co-formulated tablets (Table VI) and in their single dosage forms (Table VII) . The results shown in Tables VI and VII are in good agreement with those obtained using the official USP method (2) . Statistical analysis of the results obtained using Student's t-test and variance ratio F-test (22) revealed no significant difference between the performance of the methods regarding accuracy and precision, respectively ( Figure 6 ).
Discussion
The present study describes two methods for the simultaneous determination of MET and ASP in combined pharmaceutical dosage forms. These methods are first derivative ultraviolet spectrophotometry and HPLC methods. The derivative procedure is based on the linear relationship between the drug concentration and the first derivative amplitudes at 257 and 310 nm for MET and ASP, respectively. The method permitted the quantitation of both drugs in their co-formulated tablets. The HPLC method permitted the separation of the two drugs with good resolution in a reasonable time ,8 min. Additionally, it permitted the quantitation of both drugs in their co-formulated tablets.
Conclusion
The present study represents the first report of analytical methods for the separation of MET and ASP in their co-formulated tablets. The proposed methods for the simultaneous determination of ASP and MET proved to be reliable, simple, accurate and precise. In addition, they could be applied to the analysis of both drugs in their co-formulated tablets in challenging ratio of MET relative to ASP (1:65). The proposed HPLC method is very rapid, where the total analytical run time is ,8 min. Compared with the spectrophotometric method, the HPLC method is more sensitive and specific. The good validation criteria of the proposed methods allow their use in quality control laboratories.
